Hypercholesteremia Clinical Trial
Official title:
Effectiveness of Phytosterol Supplementation on Select Indices of Cardiovascular Risk
This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementation.
This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol
metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12
weeks of supplementation.
The study recruited 72 men and women 20-70 years of age with mild hypercholesteremia (>130
mg/dl LDL-C). They were assigned to 1 of 2 groups. Participants ingested the supplement or a
placebo for 12 weeks, with an interim assessment at 6 weeks. Participants agreed to maintain
current diet, medication, and exercise habits and to not donate blood during the trial.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05164185 -
The Effect of Remote Ischemic Conditioning in Patients With Hypercholesterolemia
|
N/A | |
Completed |
NCT00329160 -
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
|
Phase 4 | |
Completed |
NCT02634151 -
A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
|
Phase 2 | |
Completed |
NCT02587416 -
Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02722408 -
Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)
|
Phase 2 | |
Completed |
NCT00239330 -
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
|
Phase 3 | |
Recruiting |
NCT01890889 -
Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health
|
N/A | |
Completed |
NCT00376584 -
Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)
|
Phase 3 | |
Completed |
NCT01477944 -
Pattern of Statins Use in Catalonia
|
N/A | |
Completed |
NCT00688454 -
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
|
N/A | |
Completed |
NCT00347217 -
Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
|
Phase 4 | |
Completed |
NCT01354327 -
Effects of Limicol on LDL-cholesterol
|
N/A | |
Completed |
NCT03634436 -
The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT00225589 -
A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)
|
Phase 3 | |
Completed |
NCT02850224 -
Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes
|
N/A | |
Completed |
NCT00408382 -
Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque
|
Phase 4 |